For example, LA was associated with a higher risk of thrombosis (OR 3.6, 95% CI 1.2–10.9) than anti-β2GPI (OR 2.4, 95%CI 1.3–4.2) and anti-prothrombin (anti-PT) antibodies (OR 1.4, 95% CI 1.0–2.1) in the Leiden thrombophilia study (62). This evidence concerns the gene APOH and Venous thrombosis.